Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Resources › Webinars › Demystifying COVID-19 Antibody Testing
August 12, 2020
Sponsored by
Truvian

Demystifying COVID-19 Antibody Testing

Genome Webinar

Join or Log in for Access

This content is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Antibody testing is expected to play an important role in the management of the COVID-19 pandemic. With the cluttered landscape of both lab-based and lateral flow serology testing options, it has become challenging to know which way to lean, and where the cross section of accuracy and access lie. 

Sponsored by
Sep
30
Featured Webinar

Moving from Non-Invasive Prenatal Screening to Prenatal Diagnostics: An Expert Panel Discussion

Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Oct
09
Featured Webinar

Navigating the FDA's EUA Process for Diagnostics in the Present and Future: A Stakeholder Panel Discussion

Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.

What's Popular?

In Molecular Diagnostics

  1. BioReference Settles False Claims, Kickback Allegations for $11.5M

  2. UBS Downgrades Illumina to Neutral; Expresses Doubts About Grail Deal

  3. Becton Dickinson Submits Premarket Approval Supplement to FDA for HPV Assay

  4. FDA Grants Emergency Use Authorization for GK Pharmaceuticals Coronavirus Test

  5. Grail Deal Will Enable Illumina to Expand From Tech Innovator to Diagnostics Provider

    Premium

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.